The effects of L-carnitine on renal function and gene expression of caspase-9 and Bcl-2 in monosodium glutamate-induced rats.


Journal

BMC nephrology
ISSN: 1471-2369
Titre abrégé: BMC Nephrol
Pays: England
ID NLM: 100967793

Informations de publication

Date de publication:
02 05 2021
Historique:
received: 23 11 2020
accepted: 19 04 2021
entrez: 2 5 2021
pubmed: 3 5 2021
medline: 12 2 2022
Statut: epublish

Résumé

Monosodium glutamate (MSG) is frequently consumed as a flavor enhancer or food additive. Possible damages induced by MSG effects on some organs have been stated in experimental animal models. The aim of the present study was to evaluate the protective effects of L-carnitine (L-ca) on the renal tissue in MSG-Induced Rats. In this regard, 60 male rats were randomly divided into six groups (n = 10/each): 1 (Control); 2 (sham); 3 (L-carnitine 200 mg/kg b.w); 4 (MSG 3 g/kg b.w); 5 (MSG + L-carnitine 100 mg/kg); and 6 (MSG + L-carnitine 200 mg/kg). After 6 months, the rats were sacrificed, the blood sample collected and the kidneys harvested for evaluation of biochemical analytes, genes expression, and histopathological changes. MSG significantly increased the serum level of MDA, BUN, creatinine, uric acid and renal Caspase-9, NGAL and KIM-1 expression, but it decreased the serum activity also renal expression of SOD, catalase, GPX, and Bcl-2 expression compared to the control group. Treatment with L-ca significantly reduced the serum BUN, creatinine, uric acid and MDA level and increased catalase, GPX and SOD compared to the MSG group. However, only administration of L-ca 200 significantly decreased the caspase-9, NGAL and KIM-1; also, it increased the Bcl-2 expression in the kidney compared to the MSG group. Our findings indicated that L-carnitine had a major impact on the cell protection and might be an effective therapy in ameliorating the complications of the kidney induced by MSG via its antioxidant and anti-apoptotic properties.

Sections du résumé

BACKGROUND
Monosodium glutamate (MSG) is frequently consumed as a flavor enhancer or food additive. Possible damages induced by MSG effects on some organs have been stated in experimental animal models. The aim of the present study was to evaluate the protective effects of L-carnitine (L-ca) on the renal tissue in MSG-Induced Rats.
METHODS
In this regard, 60 male rats were randomly divided into six groups (n = 10/each): 1 (Control); 2 (sham); 3 (L-carnitine 200 mg/kg b.w); 4 (MSG 3 g/kg b.w); 5 (MSG + L-carnitine 100 mg/kg); and 6 (MSG + L-carnitine 200 mg/kg). After 6 months, the rats were sacrificed, the blood sample collected and the kidneys harvested for evaluation of biochemical analytes, genes expression, and histopathological changes.
RESULTS
MSG significantly increased the serum level of MDA, BUN, creatinine, uric acid and renal Caspase-9, NGAL and KIM-1 expression, but it decreased the serum activity also renal expression of SOD, catalase, GPX, and Bcl-2 expression compared to the control group. Treatment with L-ca significantly reduced the serum BUN, creatinine, uric acid and MDA level and increased catalase, GPX and SOD compared to the MSG group. However, only administration of L-ca 200 significantly decreased the caspase-9, NGAL and KIM-1; also, it increased the Bcl-2 expression in the kidney compared to the MSG group.
CONCLUSIONS
Our findings indicated that L-carnitine had a major impact on the cell protection and might be an effective therapy in ameliorating the complications of the kidney induced by MSG via its antioxidant and anti-apoptotic properties.

Identifiants

pubmed: 33933022
doi: 10.1186/s12882-021-02364-4
pii: 10.1186/s12882-021-02364-4
pmc: PMC8088661
doi:

Substances chimiques

Antioxidants 0
Bcl2 protein, rat 0
Proto-Oncogene Proteins c-bcl-2 0
Phosphorus 27YLU75U4W
Malondialdehyde 4Y8F71G49Q
Catalase EC 1.11.1.6
Glutathione Peroxidase EC 1.11.1.9
Superoxide Dismutase EC 1.15.1.1
Casp9 protein, rat EC 3.4.22.-
Caspase 9 EC 3.4.22.-
Carnitine S7UI8SM58A
Calcium SY7Q814VUP
Sodium Glutamate W81N5U6R6U

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

162

Références

Iran J Basic Med Sci. 2019 Apr;22(4):376-383
pubmed: 31168341
PLoS Biol. 2015 May 20;13(5):e1002151
pubmed: 25992600
Toxicol Mech Methods. 2012 Oct;22(8):625-30
pubmed: 22827614
Indian J Exp Biol. 2009 Mar;47(3):186-92
pubmed: 19405384
J Food Drug Anal. 2017 Apr;25(2):447-459
pubmed: 28911689
Zhonghua Nan Ke Xue. 2011 May;17(5):422-6
pubmed: 21837952
MethodsX. 2020 Oct 20;7:101113
pubmed: 33204654
Clin Exp Reprod Med. 2020 Sep;47(3):155-160
pubmed: 32911587
BMC Endocr Disord. 2020 Oct 29;20(1):162
pubmed: 33121469
Am J Kidney Dis. 2008 Sep;52(3):595-605
pubmed: 18725016
Int J Mol Sci. 2019 Dec 30;21(1):
pubmed: 31906008
J Hypertens. 2000 Jun;18(6):655-73
pubmed: 10872549
Bio Protoc. 2020 May 20;10(10):e3629
pubmed: 33659302
Iran J Kidney Dis. 2019 Mar;13(2):74-86
pubmed: 30988244
Eur J Pharmacol. 2011 Oct 15;668(3):407-13
pubmed: 21839078
FEBS Lett. 2000 Jul 28;478(1-2):19-25
pubmed: 10922462
Int J Nephrol. 2012;2012:465897
pubmed: 22577546
Int J Cardiol. 2006 Feb 8;107(1):54-60
pubmed: 16337498
Biomed Pharmacother. 2018 Dec;108:799-808
pubmed: 30253372
Int J Prev Med. 2020 Feb 17;11:16
pubmed: 32175056
Avicenna J Phytomed. 2019 Jan-Feb;9(1):72-83
pubmed: 30788280
Int J Reprod Biomed. 2018 Jun 13;17(5):
pubmed: 31435617
Immunol Today. 1994 Jan;15(1):7-10
pubmed: 8136014
Mol Cell Biochem. 2007 Sep;303(1-2):161-6
pubmed: 17458517
Cell Death Dis. 2018 Mar 6;9(3):365
pubmed: 29511177
Environ Sci Pollut Res Int. 2020 Jun;27(16):20014-20024
pubmed: 32236804
J Cardiovasc Pharmacol. 2004 May;43(5):698-705
pubmed: 15071358
Biochem J. 2004 Mar 1;378(Pt 2):485-95
pubmed: 14616091
Open Biol. 2018 May;8(5):
pubmed: 29769323
Life Sci. 2014 Jun 27;107(1-2):27-31
pubmed: 24802127
Kidney Blood Press Res. 2016;41(6):911-918
pubmed: 27889773
Gene. 2021 Jan 5;764:145083
pubmed: 32860902
Med Sci Sports Exerc. 2010 Oct;42(10):1809-18
pubmed: 20216464
Pol Merkur Lekarski. 2020 Apr 22;48(284):124-127
pubmed: 32352946
J Diabetes Metab Disord. 2020 Sep 15;19(2):1879-1894
pubmed: 33520867
Amino Acids. 2008 Aug;35(2):419-23
pubmed: 17906977
Environ Sci Pollut Res Int. 2016 Oct;23(20):20600-20608
pubmed: 27464663
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
J Mol Histol. 2010 Apr;41(2-3):121-8
pubmed: 20446105
Oxid Med Cell Longev. 2017;2017:8416763
pubmed: 28819546
Ren Fail. 2014 Mar;36(2):266-70
pubmed: 24188378
Curr Protein Pept Sci. 2017;18(12):1211-1217
pubmed: 27634444
J Biomed Sci. 2015 Oct 22;22:93
pubmed: 26493866
Life Sci. 2016 Mar 15;149:114-9
pubmed: 26905191
PLoS One. 2014 Dec 31;9(12):e116233
pubmed: 25551610
Clin Chim Acta. 2018 Dec;487:15-21
pubmed: 30201372
Asia Pac J Clin Nutr. 2008;17 Suppl 1:376-9
pubmed: 18296383
Indian J Biochem Biophys. 2006 Feb;43(1):20-4
pubmed: 16955747
Compr Rev Food Sci Food Saf. 2019 Jul;18(4):1111-1134
pubmed: 31920467
Int J Reprod Biomed. 2019 May 28;17(4):
pubmed: 31435603
Biology (Basel). 2020 Dec 30;10(1):
pubmed: 33396868
Int J Mol Sci. 2019 Oct 22;20(20):
pubmed: 31652595

Auteurs

Farhad Koohpeyma (F)

Shiraz Endocrinology and Metabolism Research Center, Shiraz University of Medical Sciences, 719363-5899, Shiraz, Iran.

Morvarid Siri (M)

Autophagy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Shaghayegh Allahyari (S)

Department of Genetic, Arsanjan Branch, Islamic Azad University, Fars, Iran.

Marzieh Mahmoodi (M)

Department of Clinical Nutrition, School of Nutrition and Food Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.

Forough Saki (F)

Shiraz Endocrinology and Metabolism Research Center, Shiraz University of Medical Sciences, 719363-5899, Shiraz, Iran.

Sanaz Dastghaib (S)

Shiraz Endocrinology and Metabolism Research Center, Shiraz University of Medical Sciences, 719363-5899, Shiraz, Iran. suny.respina@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH